Denali Therapeutics (DNLI) Insider Trading & Ownership $24.68 +0.18 (+0.73%) (As of 11/26/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Denali Therapeutics (NASDAQ:DNLI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$6.31 M Get DNLI Insider Trade Alerts Want to know when executives and insiders are buying or selling Denali Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DNLI Insider Buying and Selling by Quarter Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Denali Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/7/2024Alexander O SchuthInsiderSell15,558$29.91$465,339.78 11/7/2024Vicki L SatoDirectorSell1,020$30.00$30,600.00 10/18/2024Ryan J WattsCEOSell40,000$27.69$1,107,600.00 9/30/2024Steve E KrognesDirectorSell30,000$29.03$870,900.00 7/1/2024Steve E KrognesDirectorSell30,000$22.12$663,600.00 6/13/2024Steve E KrognesDirectorSell688$21.79$14,991.52 I've got news for you… (Ad)Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman6/6/2024Jennifer E CookDirectorSell1,458$21.73$31,682.34 4/15/2024Vicki L SatoDirectorSell1,666$18.29$30,471.14 4/1/2024Steve E KrognesDirectorSell92,500$20.50$1,896,250.00 2/15/2024Vicki L SatoDirectorSell1,666$18.37$30,604.42 2/13/2024Carole HoInsiderSell2,784$17.29$48,135.36 2/13/2024Ryan J WattsCEOSell9,589$17.29$165,793.81 2/13/2024Steve E KrognesDirectorSell2,750$17.29$47,547.50 1/16/2024Vicki L SatoDirectorSell1,666$18.42$30,687.72 1/10/2024Carole HoInsiderSell4,668$19.02$88,785.36 1/9/2024Ryan J WattsCEOSell7,818$19.78$154,640.04 1/5/2024Carole HoInsiderSell9,972$19.43$193,755.96 1/5/2024Ryan J WattsCEOSell17,483$19.43$339,694.69 1/5/2024Steve E KrognesDirectorSell3,208$19.43$62,331.44 12/15/2023Vicki L SatoDirectorSell1,666$23.39$38,967.74 (Data available from 1/1/2013 forward) DNLI Insider Trading Activity - Frequently Asked Questions Who is on Denali Therapeutics's Insider Roster? The list of insiders at Denali Therapeutics includes Alexander O Schuth, Carole Ho, Jennifer E Cook, Marc Tessier-Lavigne, Ryan J Watts, Steve E Krognes, and Vicki L Sato. Learn more on insiders at DNLI. What percentage of Denali Therapeutics stock is owned by insiders? 7.90% of Denali Therapeutics stock is owned by insiders. Learn more on DNLI's insider holdings. Which Denali Therapeutics insiders have been selling company stock? The following insiders have sold DNLI shares in the last 24 months: Alexander O Schuth ($1,470,393.86), Carole Ho ($950,856.53), Jennifer E Cook ($31,682.34), Ryan J Watts ($3,829,413.31), Steve E Krognes ($3,810,529.72), and Vicki L Sato ($406,482.92). How much insider selling is happening at Denali Therapeutics? Insiders have sold a total of 425,563 Denali Therapeutics shares in the last 24 months for a total of $10,499,358.68 sold. Denali Therapeutics Key ExecutivesDr. Ryan J. Watts Ph.D. (Age 48)Co-Founder, President, CEO & Director Compensation: $1.15MDr. Alexander O. Schuth M.D. (Age 51)Co-Founder, CFO, COO & Secretary Compensation: $802.29k1 recent tradesDr. Marc Tessier-Lavigne Ph.D. (Age 64)Co-Founder & Independent Director Compensation: $57.5kDr. Carole Ho M.D. (Age 51)Chief Medical Officer & Head of Development Compensation: $802.29kMr. Tyler M. Nielsen (Age 46)Senior Vice President of Corporate Finance Dr. Dana AndersenChief Technical and Manufacturing OfficerMr. Joe Lewcock Ph.D.Chief Scientific OfficerDr. Laura HansenVice President of Investor RelationsMr. Chris WalshGeneral CounselMr. Mark RowenVice President of Corporate Development More Insider Trading Tools from MarketBeat Related Companies NBIX Insider Ownership TECH Insider Ownership PCVX Insider Ownership EXEL Insider Ownership RVMD Insider Ownership RGEN Insider Ownership HALO Insider Ownership KRYS Insider Ownership ADMA Insider Ownership ACLX Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:DNLI) was last updated on 11/27/2024 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Denali Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Denali Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DNLI Stock Alerts